ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$HTD:NYSE · CORCEPT THERAPEUTICS INC

Sector: financefintech

52-week range: 21.9026.35

A pharmaceutical company that develops and markets drugs targeting cortisol regulation, including Korlym for Cushing's syndrome and related pipeline candidates.

4 tracked filer(s) hold this · 1 opened, 2 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 63 — mean of 4 scored holder(s) · buyers (new/add) avg 64. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Larry Robbins / Glenview61New buy4,800$553,1040.0%
Bridgewater55Added +366%268,180$30,902,3810.1%
Steve Cohen / Point7275Added +631%73,800$8,503,9740.0%
Paul Tudor Jones / Tudor61Trimmed -4%24,093$2,776,2360.0%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.